Noxopharm Limited (NOXOF)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -0.01 AUD | 76.31% |
| 2023 | -0.05 AUD | 19.66% |
| 2022 | -0.06 AUD | -81.07% |
| 2021 | -0.04 AUD | -1670.0% |
| 2020 | -0.00 AUD | 97.54% |
| 2019 | -0.08 AUD | 45.87% |
| 2018 | -0.15 AUD | -331.03% |
| 2017 | -0.03 AUD | -319.28% |
| 2016 | -0.01 AUD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | -0.00 AUD | 78.82% |
| 2024 FY | - AUD | 76.31% |
| 2024 Q1 | -0.00 AUD | 86.97% |
| 2024 Q2 | -0.01 AUD | -97.67% |
| 2024 Q4 | -0.00 AUD | 0.0% |
| 2023 FY | - AUD | 19.66% |
| 2023 Q3 | -0.02 AUD | 11.29% |
| 2023 Q4 | -0.03 AUD | -100.0% |
| 2023 Q2 | -0.02 AUD | -100.0% |
| 2023 Q1 | -0.01 AUD | 72.97% |
| 2022 Q2 | -0.03 AUD | -99.33% |
| 2022 Q4 | -0.03 AUD | -101.17% |
| 2022 FY | - AUD | -81.07% |
| 2022 Q1 | -0.02 AUD | -64.84% |
| 2022 Q3 | -0.02 AUD | 42.81% |
| 2021 Q2 | -0.03 AUD | -100.0% |
| 2021 FY | - AUD | -1670.0% |
| 2021 Q3 | -0.00 AUD | 86.62% |
| 2021 Q4 | -0.01 AUD | -116.67% |
| 2021 Q1 | -0.02 AUD | -150.16% |
| 2020 Q4 | 0.03 AUD | 44.24% |
| 2020 FY | - AUD | 97.54% |
| 2020 Q2 | -0.05 AUD | -78.37% |
| 2020 Q1 | -0.03 AUD | 42.21% |
| 2020 Q3 | 0.02 AUD | 143.14% |
| 2019 Q1 | -0.01 AUD | 46.74% |
| 2019 Q4 | -0.05 AUD | -55.91% |
| 2019 Q3 | -0.03 AUD | -112.93% |
| 2019 Q2 | -0.01 AUD | 0.0% |
| 2019 FY | - AUD | 45.87% |
| 2018 Q4 | -0.03 AUD | 0.0% |
| 2018 FY | - AUD | -331.03% |
| 2018 Q1 | -0.06 AUD | -457.14% |
| 2018 Q2 | -0.06 AUD | 0.16% |
| 2018 Q3 | -0.03 AUD | 55.7% |
| 2017 FY | - AUD | -319.28% |
| 2017 Q1 | -0.01 AUD | 38.81% |
| 2017 Q4 | -0.01 AUD | 0.0% |
| 2017 Q2 | -0.01 AUD | 0.0% |
| 2017 Q3 | -0.01 AUD | -36.59% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q2 | -0.00 AUD | 0.0% |
| 2016 Q4 | -0.01 AUD | 0.0% |